Ned 19

Research use only, not for human use.

Ned 19, a selective membrane-permeant non-competitive antagonist of NAADP, strongly inhibits tumor growth, vascularization, and lung metastases in mice.

Ned 19 is a selective membrane-permeant non competitive NAADP antagonist and inhibits NAADP-mediated Ca2+ signaling, with anIC50 of 65 nM. Ned 19 strongly inhibits tumor growth and vascularization as well as lung metastases in mice.

Ned 19 (25-100 μM; 24-72?hours) reduces cell proliferation.Ned 19 (25-100 μM; 24-72?hours) reduces markedly the cell number.Ned 19 (25-100 μM; 24-72?hours) reduces the S phase percentage and increases of the G0/G1 phase percentage evaluated by cell cycle analysis. Ned 19 (25-100 μM; 24-72?hours) induces cell apoptosis a time-dependent manner. Ned 19 (25-100 μM; 24-72?hours) reduces expression of N-cadherin and increases expression of E-cadherin, affecting the cell migratory behavior. Cell Proliferation Assay Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced cell proliferation.Cell Viability Assay Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced markedly the cell number. Cell Cycle Analysis Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced the S phase percentage and increased of the G0/G1 phase percentage.Apoptosis AnalysisCell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Induced cell apoptosis a time-dependent manner.Western Blot Analysis Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced expression of N-cadherin and increased expression of E-cadherin.

Ned 19 (i.p.; 5?mg/Kg/every second day; 4 week) impaires severely tumor growth. Animal Model:Adult male C57BL/6 mice Dosage:5?mg/Kg Administration:I.p.; every second day; 4 week Result:Impaired severely tumor growth.

——

GPCR/G Protein

Calcium Channel

Calcium Channel

——

——

874374-25-1

514.59

C30H31FN4O3

>98% (HPLC)

In Vitro:?DMSO : 125 mg/mL (242.91 mM; Ultrasonic )

C(O)(=O)C1CC2=C(C(N1)C3=CC(CN4CCN(CC4)C5=C(F)C=CC=C5)=C(OC)C=C3)NC=6C2=CC=CC6

——

(-20℃)

With Ice Pack

≥ 2 years